(Amendment)ICB/EPSA6/MOH-SDG-MOFED/FH/PH/15/22)
December 22, 2022
Tender Code: ICB/EPSA6/MOH-SDG-MOFED/FH/PH/15/22)
Tender Type: ICB
Closed Date: 01/02/2023 2:00pm
Opening Date: 01/02/2023 2:30pm
Product category: pharmaceuticals
Download File: Download
To all participants of Tender number: ICB/EPSA6/MOH-SDG-MOFED/FH/PH/15/22
Subject: – Amendment on the Bid Document
Dear Sir/Madam
Reference is made to the above tender on the Bid Document. All the participants are expected to correct all the necessary documents accordingly.
- The tender closing and opening date remains the same.
- Regarding Item no.29 Medroxyprogesterone Acetate– 150mg/ml vial – injection(Aqueous Suspension) with syringe (3 ml) 21G needle
- Quantity Adjustment
Item no. | Description | Unit | Adjusted quantity | Remark |
29 | Medroxyprogesterone Acetate– 150mg/ml vial – injection
(Aqueous Suspension) with syringe (3 ml) 21G needle |
Vial | 6,654,312 |
- An evaluation criteria amendment
- For (Medroxyprogesterone Acetate– 150mg/ml vial – injection(Aqueous Suspension)
- Manufacturers shall have Valid WHO prequalification with the manufacturing site listed on and before tender closing date, otherwise it will be rejected.
- For syringe (3 ml) 21G needle
- Valid (renewed)EFDA/EFDA GMP/CE/US-FDA product certificate.
- All other terms and conditions remain the same.
We apologies for the inconvenience you may face.
With Regards
CC:
- Deputy Director General (Inbound Logistics)
- Program Pharmaceuticals Tender Management Team
- Archive
EPSA